What is Nuvation Bio's other commercial liabilities?

Nuvation Bio (NUVB) reported other commercial liabilities of $32.86M in Q1 2026.

How has Nuvation Bio's other commercial liabilities changed year-over-year?

Nuvation Bio's other commercial liabilities increased by 37.6% year-over-year, from $23.89M to $32.86M.

What is the long-term trend for Nuvation Bio's other commercial liabilities?

Over 5 years (2020 to 2025), Nuvation Bio's other commercial liabilities has grown at a 59.5% compound annual growth rate (CAGR), from $4.38M to $45.18M.

Nuvation Bio NUVB Other Commercial Liabilities

Other Commercial Liabilities at other companies

ArriVent BioPharma, Inc.AVBP

——

IDEAYA Biosciences, Inc.IDYA

——

ImmunityBio, Inc.IBRX

——

Summit TherapeuticsSMMT

——

Roivant SciencesROIV

——

Nektar TherapeuticsNKTR

——

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's other commercial liabilities?: Nuvation Bio (NUVB) reported other commercial liabilities of $32.86M in Q1 2026.
How has Nuvation Bio's other commercial liabilities changed year-over-year?: Nuvation Bio's other commercial liabilities increased by 37.6% year-over-year, from $23.89M to $32.86M.
What is the long-term trend for Nuvation Bio's other commercial liabilities?: Over 5 years (2020 to 2025), Nuvation Bio's other commercial liabilities has grown at a 59.5% compound annual growth rate (CAGR), from $4.38M to $45.18M.